Genomic Selection Platform Global Market Report 2025
상품코드:1855894
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
게놈 선택 플랫폼 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 19억 4,000만 달러에서 2025년에는 22억 7,000만 달러로 CAGR 17.3%로 확대합니다. 지난 기간 중의 성장은 농업 생명공학의 확대, 육종 프로그램에서 양적 유전학의 사용 증가, 작물 및 가축의 질병 저항성에 대한 관심 증가, 공동 연구 구상의 성장, 질병 압력 및 기후 변화로 인한 과제 증가와 관련이 있습니다.
유전체 선택 플랫폼 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 16.9%로 42억 5,000만 달러로 성장할 것입니다. 예측 기간 중의 성장은 전 세계 식량 수요 증가, 정밀농업의 확대, 지속가능한 육종 방법에 대한 관심 증가, 가축 유전체학의 성장, 육종 위탁 및 유전체 서비스의 부상과 연관 지어 볼 수 있습니다. 예측 기간 중 주요 동향으로는 차세대 염기서열 분석기(NGS)의 발전, 디지털 농업 툴와의 통합, AI 및 머신러닝 채택, 클라우드 기반 유전체 데이터 플랫폼 도입, 멀티오믹스 데이터 통합 등을 들 수 있습니다.
유전체 선발 플랫폼은 유전체 차원의 유전정보를 활용하여 식물, 동물, 미생물의 성능 및 육종 가능성을 예측하는 기술 주도형 시스템입니다. 가장 바람직한 형질을 가진 개체를 조기에 파악하여 기존의 긴 평가 주기의 필요성을 최소화하고, 선택적 육종을 가속화할 수 있습니다. 이 플랫폼은 고처리량 유전형질 분석, 통계적 모델링, 예측 알고리즘을 통합하여 효율적이고 정보에 입각한 선발 결정을 내릴 수 있도록 합니다.
유전체 선택 플랫폼의 주요 구성 요소는 소프트웨어, 하드웨어, 서비스입니다. 소프트웨어에는 육종 프로그램을 지원하기 위해 대규모 유전체 데이터를 처리하고 분석하기 위해 설계된 전문 계산 툴와 용도이 포함되어 있습니다. 이는 On-Premise 또는 클라우드 기반 시스템을 통해 구현할 수 있으며, 식물 육종, 동물 육종, 인간 유전체 분석 등에 적용됩니다. 주요 최종사용자는 연구기관, 생명공학 기업, 농업 단체, 기타 이해관계자 등입니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 그에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단 기기, 의약품 공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.
이 조사 보고서는 유전체 선택 플랫폼 산업 세계 시장 규모, 지역 점유율, 유전체 선택 플랫폼 시장 점유율을 가진 경쟁사, 상세한 유전체 선택 플랫폼 시장 부문, 시장 동향, 비즈니스 기회 등 유전체 선택 플랫폼 시장 통계를 제공합니다. The Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 유전체 선택 플랫폼 시장 조사 보고서는 업계의 현재와 미래 시나리오에 대한 상세한 분석을 통해 필요한 모든 것을 완벽하게 전망합니다.
맞춤형 의료의 도입 확대는 유전체 선택 플랫폼 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 체질, 생활습관, 환경에 따라 치료 및 예방 전략을 조정하는 것입니다. 이러한 추세는 유전체학의 발전으로 유전자 변이의 정확한 식별과 맞춤형 치료법 개발이 가능해짐에 따라 더욱 가속화되고 있습니다. 유전체 선별 플랫폼은 유전체에 대한 정확한 인사이트를 제공하고, 환자 개개인을 위해 특별히 설계된 치료를 가능하게 함으로써 맞춤형 의료를 지원하는 데 중요한 역할을 하고 있습니다. 이러한 플랫폼은 환자가 다양한 중재에 어떻게 반응할지를 예측하여 치료법 선택에 있으며, 시행착오를 최소화하고, 궁극적으로 치료 효과와 환자 결과를 개선할 수 있습니다. 예를 들어 2024년 2월, 맞춤형 의료 연합은 미국 식품의약국이 2023년 26개의 개인화 신약을 승인하여 2022년 12개에서 증가했다고 보고했습니다. 이러한 증가는 맞춤형 의료의 역할이 확대되고 있으며, 유전체 선별 플랫폼에 대한 수요를 촉진하고 있습니다.
작물 수확량 증가는 유전체 선택 플랫폼 시장의 성장을 가속할 것으로 예측됩니다. 작물 수확량은 단위 면적당 생산되는 농업 생산물의 양을 의미하며, 식물 유전학 및 회복력을 향상시키는 농업 생명공학 기술의 발전으로 인해 증가하고 있습니다. 유전체 선발 플랫폼은 고성능 식물 품종을 정확하게 선발할 수 있게 함으로써 작물 수확량 향상에 중요한 역할을 하고 있으며, 현대 농업과 육종 프로그램에 필수적인 역할을 하고 있습니다. 이러한 플랫폼은 정확한 유전적 예측을 제공함으로써 기존 육종 방법과 관련된 시간과 비용을 절감하고, 농장의 생산성과 식량안보를 향상시킬 수 있습니다. 예를 들어 2024년 2월 환경식품농촌지역부는 2022년 영국의 곡물 생산량이 2,430만 톤에 달하고, 2021년 대비 8% 증가했다고 발표했습니다. 이러한 작물 수확량 증가는 농업에서 유전체 선택 플랫폼의 중요성을 더욱 부각시키고 있습니다.
유전체 선택 플랫폼 시장의 주요 기업은 형질 예측을 개선하고 육종 프로그램을 가속화하기 위해 타겟 시퀀싱 플랫폼과 같은 혁신적인 솔루션 개발에 점점 더 집중하고 있습니다. 타겟 시퀀싱 플랫폼은 전체 유전체의 염기서열이 아닌, 유전체의 특정 영역의 염기서열에 초점을 맞춘 유전체 기술입니다. 예를 들어 2024년 10월 Element Biosciences는 기존의 복잡한 단계를 AVITI System에 통합하여 엑솜 캡처를 간소화하도록 설계된 획기적인 타겟 시퀀싱 플랫폼인 Trinity를 발표했습니다. 이 플랫폼은 특별한 장비가 필요하지 않고, 수작업을 최대 5시간 단축하고, 1시간의 하이브리드화 옵션으로 당일 결과를 얻을 수 있으며, 시간적 제약이 있는 연구에 매우 적합합니다. Trinity는 암, 호흡기 질환, 미세잔존질환(MRD) 등 다양한 용도의 맞춤형 패널로 확장할 수 있으며, 보다 빠르고 비용 효율적이며 접근이 용이한 시퀀싱을 제공합니다. 이는 엑솜 포획 기술의 큰 진전이라고 할 수 있습니다.
유전체 선발 플랫폼 시장은 유전형질분석, 페노타이핑, 데이터 분석 및 해석, 예측 모델링, 육종 프로그램 관리, 컨설팅 서비스 등의 서비스를 제공하는 사업체들의 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 유전체 선택 플랫폼 시장에는 유전형질 분석 플랫폼, 시퀀싱 플랫폼, 생물정보학 소프트웨어, 데이터 분석 툴, 마커 지원 선택 툴, DNA 추출 키트, 하이스루풋 유전형질 분석의 매출도 포함됩니다. 이 시장의 가치는 '팩토리 게이트'의 가치이며, 다른 사업체(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 등)이든 직접 최종 고객이든, 상품의 제조자 또는 제작자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 게놈 선택 플랫폼 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 게놈 선택 플랫폼 시장 : 성장률 분석
세계의 게놈 선택 플랫폼 시장 실적 : 규모와 성장, 2019-2024
세계의 게놈 선택 플랫폼 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 게놈 선택 플랫폼 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 게놈 선택 플랫폼 시장 : 컴포넌트별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소프트웨어
하드웨어
서비스
세계의 게놈 선택 플랫폼 시장 : 배포 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
온프레미스
클라우드 기반
세계의 게놈 선택 플랫폼 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
식물 육종
동물 육종
인간 유전체학
기타 용도
세계의 게놈 선택 플랫폼 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
연구기관
바이오테크놀러지 기업
농업단체
기타 최종사용자
세계의 게놈 선택 플랫폼 시장 : 서브 세분화 소프트웨어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
게놈 데이터 관리 소프트웨어
바이오인포매틱스와 통계 해석 툴
DNA 또는 RNA 시퀀스 데이터 처리 소프트웨어
게놈 예측 및 모델링 소프트웨어
클라우드 기반 게놈 플랫폼
워크플로우 자동화와 통합 툴
세계의 게놈 선택 플랫폼 시장 : 서브 세분화 하드웨어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀀스(NGS) 시스템
중합효소 연쇄 반응(PCR) 기기
마이크로어레이 애널라이저
고성능 컴퓨팅(HPC) 시스템
데이터 스토리지 서버
실험실 자동화와 로보틱스
세계의 게놈 선택 플랫폼 시장 : 서브 세분화 서비스, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
시퀀스와 지노타이핑 서비스
데이터 분석·해석 서비스
클라우드 호스팅과 데이터 스토리지 서비스
커스텀 바이오인포매틱스 솔루션
트레이닝과 기술 지원 서비스
컨설팅과 실장 서비스
제7장 지역별·국가별 분석
세계의 게놈 선택 플랫폼 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 게놈 선택 플랫폼 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
게놈 선택 플랫폼 시장 : 경쟁 구도
게놈 선택 플랫폼 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Illumina Inc.
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
MGI Tech Co. Ltd.
Azenta Inc.
10x Genomics Inc.
Oxford Nanopore Technologies plc
Ultima Genomics Inc.
Element Biosciences Inc.
DNAnexus Inc.
Deep Genomics Inc.
Epigene Labs Inc.
Quotient Therapeutics Inc.
Evogene Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
게놈 선택 플랫폼 시장 2029 : 새로운 기회를 제공하는 국가
게놈 선택 플랫폼 시장 2029 : 새로운 기회를 제공하는 부문
게놈 선택 플랫폼 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
A genomic selection platform is a technology-driven system that leverages genome-wide genetic information to predict the performance or breeding potential of plants, animals, or microorganisms. It accelerates selective breeding by identifying individuals with the most desirable traits early, minimizing the need for prolonged traditional evaluation cycles. The platform integrates high-throughput genotyping, statistical modeling, and predictive algorithms to enable efficient, informed selection decisions.
The primary components of a genomic selection platform are software, hardware, and services. Software includes specialized computational tools and applications designed to process and analyze large-scale genomic data to support breeding programs. It can be implemented through on-premises or cloud-based systems and finds applications in plant breeding, animal breeding, human genomics, and more. Key end-users comprise research institutions, biotechnology firms, agricultural organizations, and other stakeholders.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The genomic selection platform market research report is one of a series of new reports from The Business Research Company that provides genomic selection platform market statistics, including the genomic selection platform industry global market size, regional shares, competitors with the genomic selection platform market share, detailed genomic selection platform market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic selection platform industry. This genomic selection platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The genomic selection platform market size has grown rapidly in recent years. It will grow from $1.94 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be linked to the expansion of agricultural biotechnology, increasing use of quantitative genetics in breeding programs, heightened focus on disease resistance in crops and livestock, growth of collaborative research initiatives, and rising challenges from disease pressures and climate variability.
The genomic selection platform market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be linked to rising global food demand, expansion of precision agriculture, increased emphasis on sustainable breeding practices, growth in livestock genomics, and the rise of contract breeding and genomic services. Key trends during the forecast period include advancements in next-generation sequencing (NGS), integration with digital agriculture tools, adoption of AI and machine learning, implementation of cloud-based genomic data platforms, and integration of multi-omics data.
The growing adoption of personalized medicine is expected to drive the expansion of the genomic selection platform market. Personalized medicine tailors treatment and prevention strategies based on an individual's unique genetic makeup, lifestyle, and environment. This trend is largely fueled by advancements in genomics, which allow for the precise identification of genetic variations and the development of customized treatments. Genomic selection platforms play a critical role in supporting personalized medicine by offering precise genomic insights, enabling treatments that are specifically designed for each patient. These platforms minimize trial-and-error in therapy selection by predicting how patients will respond to different interventions, ultimately improving treatment effectiveness and patient outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, up from 12 in 2022. This increase highlights the growing role of personalized medicine, which is fueling the demand for genomic selection platforms.
The rise in crop yields is expected to drive growth in the genomic selection platform market. Crop yield, which refers to the amount of agricultural output produced per unit of land, is increasing due to advancements in agricultural biotechnology that improve plant genetics and resilience. Genomic selection platforms play a key role in enhancing crop yields by enabling the precise selection of high-performing plant varieties, making them essential for modern agriculture and breeding programs. These platforms reduce the time and cost associated with traditional breeding methods by offering accurate genetic predictions, which in turn boosts farm productivity and food security. For instance, in February 2024, the Department for Environment, Food and Rural Affairs reported that the UK's cereal production reached 24.3 million tonnes in 2022, an 8% increase compared to 2021. This rise in crop yields further underscores the growing importance of genomic selection platforms in agriculture.
Leading companies in the genomic selection platform market are increasingly focusing on developing innovative solutions such as targeted sequencing platforms to improve trait prediction and accelerate breeding programs. Targeted sequencing platforms are genomic technologies that focus on sequencing specific regions of the genome, rather than sequencing the entire genome. For example, in October 2024, Element Biosciences launched Trinity, a breakthrough targeted sequencing platform designed to streamline exome capture by integrating traditionally complex steps into its AVITI System. The platform eliminates the need for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it highly suitable for time-sensitive studies. Trinity can be expanded to support custom panels for various applications, including oncology, respiratory diseases, and minimal residual disease (MRD), offering faster, more cost-effective, and accessible sequencing. This marks a significant advancement in exome capture technology.
Major players in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc.
North America was the largest region in the genomic selection platform market in 2024. The regions covered in genomic selection platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the genomic selection platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genomic selection platform market consists of revenues earned by entities by providing services such as genotyping, phenotyping, data analysis and interpretation, predictive modeling, breeding program management, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic selection platform market also includes sales of genotyping platforms, sequencing platforms, bioinformatics software, data analysis tools, marker-assisted selection tools, DNA extraction kits, and high-throughput genotyping assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genomic Selection Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genomic selection platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genomic selection platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomic selection platform market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Software; Hardware; Services
2) By Deployment Mode: On-Premises; Cloud-Based
3) By Application: Plant Breeding; Animal Breeding; Human Genomics; Other Applications
4) By End-User: Research Institutes; Biotechnology Companies; Agricultural Organizations; Other End Users
Subsegments:
1) By Software: Genomic Data Management Software; Bioinformatics And Statistical Analysis Tools; DNA Or RNA Sequencing Data Processing Software; Genomic Prediction And Modeling Software; Cloud-Based Genomic Platforms; Workflow Automation And Integration Tools
2) By Hardware: Next-Generation Sequencing (NGS) Systems; Polymerase Chain Reaction (PCR) Instruments; Microarray Analyzers; High-Performance Computing (HPC) Systems; Data Storage Servers; Laboratory Automation And Robotics
3) By Services: Sequencing And Genotyping Services; Data Analysis And Interpretation Services; Cloud Hosting & Data Storage Services; Custom Bioinformatics Solutions; Training And Technical Support Services; Consulting And Implementation Services
3. Genomic Selection Platform Market Trends And Strategies
4. Genomic Selection Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Genomic Selection Platform Growth Analysis And Strategic Analysis Framework
5.1. Global Genomic Selection Platform PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomic Selection Platform Market Growth Rate Analysis
5.4. Global Genomic Selection Platform Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomic Selection Platform Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomic Selection Platform Total Addressable Market (TAM)
6. Genomic Selection Platform Market Segmentation
6.1. Global Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Hardware
Services
6.2. Global Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
On-Premises
Cloud-Based
6.3. Global Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plant Breeding
Animal Breeding
Human Genomics
Other Applications
6.4. Global Genomic Selection Platform Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Institutes
Biotechnology Companies
Agricultural Organizations
Other End Users
6.5. Global Genomic Selection Platform Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Data Management Software
Bioinformatics And Statistical Analysis Tools
DNA Or RNA Sequencing Data Processing Software
Genomic Prediction And Modeling Software
Cloud-Based Genomic Platforms
Workflow Automation And Integration Tools
6.6. Global Genomic Selection Platform Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS) Systems
Polymerase Chain Reaction (PCR) Instruments
Microarray Analyzers
High-Performance Computing (HPC) Systems
Data Storage Servers
Laboratory Automation And Robotics
6.7. Global Genomic Selection Platform Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing And Genotyping Services
Data Analysis And Interpretation Services
Cloud Hosting And Data Storage Services
Custom Bioinformatics Solutions
Training And Technical Support Services
Consulting And Implementation Services
7. Genomic Selection Platform Market Regional And Country Analysis
7.1. Global Genomic Selection Platform Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomic Selection Platform Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Genomic Selection Platform Market
9.1. China Genomic Selection Platform Market Overview
9.2. China Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Genomic Selection Platform Market
10.1. India Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Genomic Selection Platform Market
11.1. Japan Genomic Selection Platform Market Overview
11.2. Japan Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Genomic Selection Platform Market
12.1. Australia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Genomic Selection Platform Market
13.1. Indonesia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Genomic Selection Platform Market
14.1. South Korea Genomic Selection Platform Market Overview
14.2. South Korea Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Genomic Selection Platform Market
15.1. Western Europe Genomic Selection Platform Market Overview
15.2. Western Europe Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Genomic Selection Platform Market
16.1. UK Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Genomic Selection Platform Market
17.1. Germany Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Genomic Selection Platform Market
18.1. France Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Genomic Selection Platform Market
19.1. Italy Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Genomic Selection Platform Market
20.1. Spain Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Genomic Selection Platform Market
21.1. Eastern Europe Genomic Selection Platform Market Overview
21.2. Eastern Europe Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Genomic Selection Platform Market
22.1. Russia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Genomic Selection Platform Market
23.1. North America Genomic Selection Platform Market Overview
23.2. North America Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Genomic Selection Platform Market
24.1. USA Genomic Selection Platform Market Overview
24.2. USA Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
